Becker's Healthcare July 18, 2024
On July 17, KENS5 reported on a woman who was taking Wegovy, a GLP-1, regularly for weight loss but was not made aware of the potential negative interactions leading up to a bronchoscopy.
Chaplain Treanor, the patient, went into her procedure having taken Wegovy days before, according to the report.
Ozempic is FDA-approved for diabetes treatment and Wegovy is FDA-approved for weight loss.
In 2023, the American Society of Anesthesiology released guidelines stating that GLP-1s should not be used at least a week leading up to surgery due to potential risks.
Luckily, Ms. Treanor’s anesthesiologist became aware that she was taking the drug and was able to perform the procedure safely. Because GLP-1s slow down gastric...
Today's Sponsors
Today's Sponsor